Analyzing...
Loading company...
Alembic Ltd. engages in the pharmaceutical and real estate business. The company is headquartered in Vadodara, Gujarat and currently employs 305 full-time employees. The firm operates through a single segment, Pharmaceuticals. The Pharmaceuticals segment is engaged in the manufacturing and marketing of fermentation and chemistry-based Active Pharmaceuticals Ingredients (API). The firm is also engaged in research and development activity at Vadodara. The firm manufactures/provides three key products/services: Azithromycin, Venlafaxine and Telmisartan.
No significant concerns identified
Nothing flagged for monitoring
“Operates in Real Estate — Development & Construction.”
₹240 Cr revenue.
COGS 6.8%, employees 15.6%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.0%▲ | 4.7% |
| ROCE | 6.1% | 6.1% |
| Net Margin | 101.4%▲ | 7.4% |
| EBITDA Margin | 52.2%▲ | 22.0% |
| Debt To Equity | 0.00x▼ | 0.30x |
| Rev Growth 3yr | 17.8%▲ | 12.4% |
| EPS Growth 3yr | 18.5%▼ | 23.7% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹240 Cr +8.2% | ₹222 Cr +40.9% | ₹157 Cr +23.8% | ₹127 Cr +62.7% | ₹78 Cr +6.4% | ₹74 Cr -0.6% | ₹74 Cr -42.1% | ₹128 Cr |
| Other Income | ₹73 Cr -2.6% | ₹75 Cr +36.7% | ₹55 Cr -14.8% | ₹64 Cr -27.9% | ₹89 Cr +767.9% | ₹10 Cr -89.0% | ₹93 Cr +217.2% | ₹29 Cr |
| Total Income | ₹313 Cr +5.5% | ₹297 Cr +39.8% | ₹212 Cr +10.8% | ₹192 Cr +14.4% | ₹167 Cr +99.8% | ₹84 Cr -49.9% | ₹167 Cr +6.5% | ₹157 Cr |
| COGS | ₹16 Cr +80.2% | ₹9 Cr -0.3% | ₹9 Cr +44.8% | ₹6 Cr -42.5% | ₹11 Cr +17.1% | ₹9 Cr -70.2% | ₹31 Cr -29.6% | ₹45 Cr |
| ₹164 Cr +16.2% | ₹141 Cr +28.9% | ₹110 Cr +16.4% | ₹94 Cr +35.3% | ₹70 Cr +4.2% | ₹67 Cr -10.0% | ₹74 Cr -32.3% | ₹110 Cr | |
| Profit Before Tax | ₹149 Cr -4.3% | ₹156 Cr +51.4% | ₹103 Cr +18.3% | ₹87 Cr -11.3% | ₹98 Cr +474.2% | ₹17 Cr -81.7% | ₹93 Cr +95.7% | ₹48 Cr |
| ₹23 Cr +108.8% | ₹11 Cr +11.3% | ₹10 Cr +58.9% | ₹6 Cr -47.0% | ₹12 Cr +264.5% | ₹3 Cr | ₹0.13 Cr -96.8% | ₹4 Cr | |
| Net Profit | ₹317 Cr +2.2% | ₹311 Cr +15.7% | ₹269 Cr +40.9% | ₹191 Cr -14.1% | ₹222 Cr -35.2% | ₹343 Cr +4.2% | ₹329 Cr +42.8% | ₹230 Cr |
| Profit (Owners) | ₹317 Cr +2.2% | ₹311 Cr +15.7% | ₹269 Cr +40.9% | ₹191 Cr -14.1% | ₹222 Cr -35.2% | ₹343 Cr +4.2% | ₹329 Cr +42.8% | ₹230 Cr |
| Other Comprehensive Income | (₹88 Cr) -155.1% | (₹34 Cr) +42.5% | (₹60 Cr) +72.1% | (₹214 Cr) ↓ Decline | ₹107 Cr -69.0% | ₹345 Cr ↑ Recovery | (₹17 Cr) ↓ Decline | ₹16 Cr |
| EPS | ₹12.35 | ₹12.10 | ₹10.46 | ₹7.42 | ₹8.65 | ₹13.35 | ₹12.82 | ₹8.97 |
| Diluted Shares | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
| Profit Or Loss Of Associates | ₹191 Cr +15.3% | ₹166 Cr -5.5% | ₹176 Cr +59.7% | ₹110 Cr -19.0% | ₹136 Cr -58.7% | ₹329 Cr +39.4% | ₹236 Cr +26.3% | ₹187 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Alembic Limited has informed the Exchange about General Updates
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Alembic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Alembic Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Aug-2026.
Alembic Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Alembic Limited has informed the Exchange about General Updates
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011...
Alembic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Alembic Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Alembic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.